Company Profiles

driven by the PitchBook Platform

Athenex

Description

Developer of next generation therapeutics for the treatment of cancer. The company focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases.

2002

Founded

PRIVATE

Status

201-500

Employees

Later Stage VC

Latest Deal Type

$37.9M

Latest Deal Amount

$238M

Total Amount Raised

Description

Developer of next generation therapeutics for the treatment of cancer. The company focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases.

Website:

www.athenex.com

Formerly Known As

Kinex Pharmaceuticals

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Therapeutic Devices

Primary Office

1001 Main Street Suite 600 Buffalo, NY 14203United States +1 (716) 427-2950
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Athenex's full profile, request a free trial.

Athenex Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Athenex Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Erie County Industrial Development AgencyGovernmentMinority000 0000000 0000
John R. Oishei FoundationCorporationMinority000 0000000 0000
Ma HuatengAngel (individual)Minority000 0000000 0000
Mandra CapitalVenture CapitalMinority000 0000000 0000
PharminexVC-Backed CompanyMinority000 0000000 0000
Erie County Industrial Development Agency Government
John R. Oishei Foundation Corporation
Ma Huateng Angel (individual)
Mandra Capital Venture Capital
Pharminex VC-Backed Company

Athenex Executive Team (20)

NameTitleBoard
Seat
Contact
Info
Johnson Lau MDChief Executive Officer & Board Chairman
Stephen Panaro Ph.DPresident
William Zuo Ph.DPresident of Polymed Therapeutics
Jeffrey YordonPresident, Pharmaceutical Division
Flint BeseckerChief Operating & Financial Officer and Board Director
Johnson Lau MD Chief Executive Officer & Board Chairman
Stephen Panaro Ph.D President
William Zuo Ph.D President of Polymed Therapeutics
Jeffrey Yordon President, Pharmaceutical Division
Flint Besecker Chief Operating & Financial Officer and Board Director

Athenex Board Members (10)

NameRepresentingRoleSinceContact
Info
Antony LeungAthenexBoard Member000 0000
Charles LannonSelfBoard Member000 0000
Flint BeseckerAthenexChief Operating & Financial Officer and Board Director000 0000
Jean-Pierre Sommadossi Ph.DSelfBoard Member000 0000
Jinn Wu Ph.DSelfBoard Member000 0000
Antony Leung Board Member Athenex
Charles Lannon Board Member Self
Flint Besecker Chief Operating & Financial Officer and Board Director Athenex
Jean-Pierre Sommadossi Ph.D Board Member Self
Jinn Wu Ph.D Board Member Self
Request full access to PitchBook